Experts assess Nigeria’s response to COVID-19 so far and express worry that the country does not appear to have learnt much; it isn’t prepared for the next pandemic.
As ready as you are to be done with COVID-19, it’s not going anywhere soon. A historian of disease describes how once a pathogen emerges, it’s usually here to stay.
There aren’t enough international and domestic laws to address how the interests of humans and the needs of wildlife overlap.
Before a vaccine is available to teach your immune system to ward off the coronavirus, maybe you can directly use molecules that have already fought it in other people.
Emphasizing foreign origins of a disease can have racist connotations and implications for how people understand their own risk of disease.
In a health crisis, decisions about treatment and containment must be made quickly. It’s crucial those decisions be based on research evidence, but fast and easy access is not always available.
While identifying a new disease by its place of origin seems intuitive, history shows that doing so can have serious consequences for the people that live there.
The current outbreak refuses to give in to efforts by an international team of health care workers, armed with vaccines and treatment that did not even exist during previous episodes.
Nearly everything known about Ebola virus persistence in the reproductive system has resulted from testing semen of West African Ebola virus disease survivors.
Borders are porous between North Kivu province of the DRC and neighbouring countries, so the potential for spread is highly likely.
Ebola is difficult to contain because of human social and behavioural factors. But it can be if 100% of the infected people’s contacts are identified and monitored.
The way humans share the world with wildlife has rapidly changed – and this is having a serious impact on the spread of pathogens.
The current Ebola outbreak in the DRC is devastating vulnerable communities already affected by displacement and violence.
Four new Ebola treatments are being tried out in the DRC.
The new Ebola vaccine is yet to be licensed but evidence shows that it protects against the strain of the virus.
Without the current experimental vaccine the Ebola outbreak in the DRC has the potential to spiral out of control.
Instability in the DRC and Ebola’s deadly properties is making it hard to contain the virus.
Banning travel might not always be the best way to respond to a disease outbreak.
Teams administering the Ebola vaccine in the Democratic Republic of Congo are in a race against time to find and help people exposed.
Recent discoveries of ancient viruses are helping scientists understand their origins.